Carebet Co., Ltd. announced that it will issue 142,850 common shares at an issue price of KRW 21,000 per share for the gross proceeds of KRW 2,999,850,000 on October 28, 2023. The transaction will include participation from new investor Genesystem Co., Ltd. The transaction has been approved by the board of directors of the company. The transaction is expected to close on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,190 KRW | -0.16% | -0.48% | -33.65% |
03-28 | Genesystem Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
03-28 | Genesystem Co., Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.65% | 31.95M | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- A363250 Stock
- News Genesystem Co., Ltd.
- Carebet Co., Ltd. announced that it expects to receive KRW 2.99985 billion in funding from Genesystem Co., Ltd.